Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 53 results

Search term: MF = 'C_{32}H_{31}F_{2}N_{3}O_{2}'
123
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
24599682

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31-/m1/s1
C32H31F2N3O2527.60422928372
2300667

3 of 4 defined stereocentres - 3/4 defined
InChI=1/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31?/m1/s1
C32H31F2N3O2527.604246399999151200
19225999

0 of 4 defined stereocentres - 0/4 defined
InChI=1/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2
C32H31F2N3O2527.6042141100
2431817

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C32H31F2N3O2/c33-25-15-11-22(12-16-25)21-37(32(39)29-20-19-28(36-29)23-7-3-1-4-8-23)30(24-13-17-26(34)18-14-24)31(38)35-27-9-5-2-6-10-27/h1,3-4,7-8,11-20,27,30,36H,2,5-6,9-10,21H2,(H,35,38)
C32H31F2N3O2527.604212700
2431816

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C32H31F2N3O2/c33-25-17-15-23(16-18-25)30(31(38)35-26-12-5-2-6-13-26)37(21-24-11-7-8-14-27(24)34)32(39)29-20-19-28(36-29)22-9-3-1-4-10-22/h1,3-4,7-11,14-20,26,30,36H,2,5-6,12-13,21H2,(H,35,38)
C32H31F2N3O2527.604211600
45382376
InChI=1/C32H31F2N3O2/c1-20-4-13-26-23(18-32(2,3)37-29(26)27(20)30(38)31(37)39)19-35-14-16-36(17-15-35)28(21-5-9-24(33)10-6-21)22-7-11-25(34)12-8-22/h4-13,18,28H,14-17,19H2,1-3H3
C32H31F2N3O2527.60426500
25027165

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31-/m0/s1
C32H31F2N3O2527.60425300
29219296

Double-bond stereo
InChI=1/C32H31F2N3O2/c1-2-21-39-31-15-7-14-29-25(31)22-30(37(29)23-26-27(33)12-6-13-28(26)34)32(38)36-19-17-35(18-20-36)16-8-11-24-9-4-3-5-10-24/h2-15,22H,1,16-21,23H2/b11-8+
C32H31F2N3O2527.60424300
58946163
InChI=1/C32H31F2N3O2/c1-21-30(24-4-2-3-5-27(24)34)35-28-18-22(33)6-8-25(28)31(21)37-20-32(10-14-38-15-11-32)26-9-7-23(19-29(26)37)36-12-16-39-17-13-36/h2-9,18-19H,10-17,20H2,1H3
C32H31F2N3O2527.60423300
62562798

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C32H31F2N3O2/c33-25-17-15-23(16-18-25)30(31(38)35-26-12-5-2-6-13-26)37(21-24-11-7-8-14-27(24)34)32(39)29-20-19-28(36-29)22-9-3-1-4-10-22/h1,3-4,7-11,14-20,26,30,36H,2,5-6,12-13,21H2,(H,35,38)/t30-/m1/s1
C32H31F2N3O2527.60422200
76729114

Double-bond stereo
InChI=1/C32H31F2N3O2/c1-36-13-15-37(16-14-36)30-4-2-3-29(21-30)35-32(39)26-19-24(17-22-5-9-27(33)10-6-22)31(38)25(20-26)18-23-7-11-28(34)12-8-23/h2-12,17-18,21,26H,13-16,19-20H2,1H3,(H,35,39)/b24-17+,25-18+
C32H31F2N3O2527.60422200
76735356

Double-bond stereo
InChI=1/C32H31F2N3O2/c1-36-14-16-37(17-15-36)30-12-10-29(11-13-30)35-32(39)26-20-24(18-22-2-6-27(33)7-3-22)31(38)25(21-26)19-23-4-8-28(34)9-5-23/h2-13,18-19,26H,14-17,20-21H2,1H3,(H,35,39)/b24-18+,25-19+
C32H31F2N3O2527.60422200
76819597

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31+/m1/s1
C32H31F2N3O2527.60422200
135726

1 of 4 defined stereocentres - 1/4 defined
InChI=1/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29?,30?,31?/m1/s1
C32H31F2N3O2527.60422100
78315723

3 of 4 defined stereocentres - 3/4 defined
InChI=1/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21?,29-,30+,31+
C32H31F2N3O2527.60421100
110073679

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C32H31F2N3O2/c33-25-17-15-23(16-18-25)30(31(38)35-26-12-5-2-6-13-26)37(21-24-11-7-8-14-27(24)34)32(39)29-20-19-28(36-29)22-9-3-1-4-10-22/h1,3-4,7-11,14-18,20,26,30H,2,5-6,12-13,19,21H2,(H,35,38)
C32H31F2N3O2527.60421100
110073680

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C32H31F2N3O2/c33-25-15-11-22(12-16-25)21-37(32(39)29-20-19-28(36-29)23-7-3-1-4-8-23)30(24-13-17-26(34)18-14-24)31(38)35-27-9-5-2-6-10-27/h1,3-4,7-8,11-18,20,27,30H,2,5-6,9-10,19,21H2,(H,35,38)
C32H31F2N3O2527.60421100
123

Advertisement